A newly identified protein may hold the key to preventing diabetic blindness. Researchers discovered that LRG1 triggers the ...

Diabetes affects hundreds of millions of people worldwide, and one of its most feared complications is vision loss. High ...

People who get less than 6 hours of sleep on weekdays have a 25% higher risk of experiencing an epiretinal membrane.

Researchers identify the protein LRG1, which is present in the body, as a trigger of early retinal damage in diabetic ...

Individuals with type 2 diabetes — with or without retinopathy — had higher risks for incident Alzheimer’s disease and dementia than those without the blood sugar disorder. Among patients with ...

Tirzepatide use is associated with a lower incidence of new or progressive diabetic retinopathy (DR) and fewer complications.

For sura-vec in wet AMD, top line data from pivotal studies ATMOSPHERE and ASCENT are anticipated in Q4. First patient dosing in NAVIGATE for diabetic retinopathy is planned next quarter, expected to ...

Several nonmodifiable and modifiable risk factors are known to be associated with diabetic retinopathy (DR). Nonmodifiable risk factors include race or ethnicity, gender, age at diabetes onset and ...

Tirzepatide use is linked to lower risks of incident and progressive diabetic retinopathy compared with lifestyle intervention alone.

Background/aims Posterior capsule opacification (PCO) is the most frequent long-term complication after cataract surgery, ...